Back to Search Start Over

Switzerland : Novartis receives two landmark European approvals for Cosentyx to treat patients with ankylosing spondylitis and psoriatic arthritis

Switzerland : Novartis receives two landmark European approvals for Cosentyx to treat patients with ankylosing spondylitis and psoriatic arthritis

Source :
Mena Report. November 24, 2015
Publication Year :
2015

Abstract

Novartis announced today that the European Commission (EC) has approved Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and psoriatic arthritis (PsA). For AS, this is [...]

Details

Language :
English
ISSN :
22190112
Database :
Gale General OneFile
Journal :
Mena Report
Publication Type :
News
Accession number :
edsgcl.435516523